D. Western Therapeutics Institute, Inc. (TYO:4576)

TYO:4576 Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,757	8,226	4,530	7,998	6,341	8,454
Market Cap Growth	69.71%	81.59%	-43.36%	26.13%	-24.98%	-50.43%
Enterprise Value	4,227	8,125	3,321	6,755	4,779	6,542
Last Close Price	104.00	201.00	141.00	262.00	216.00	289.00
PS Ratio	11.30	17.47	10.58	17.85	15.32	23.81
PB Ratio	5.38	11.22	3.54	4.28	3.12	3.91
P/TBV Ratio	5.53	11.94	3.80	4.62	3.45	4.32
EV/Sales Ratio	10.04	17.25	7.76	15.08	11.55	18.43
EV/FCF Ratio	-5.85	-	-	-	-	-
Debt / Equity Ratio	0.59	1.09	0.69	0.52	0.17	0.21
Asset Turnover	0.24	0.23	0.16	0.17	0.16	0.15
Inventory Turnover	0.46	0.50	0.43	0.34	0.29	0.29
Quick Ratio	10.73	9.48	10.23	11.87	10.54	11.48
Current Ratio	12.76	11.17	11.02	12.60	11.20	11.98
Return on Equity (ROE)	-124.90%	-128.23%	-52.51%	-22.59%	-7.62%	-16.30%
Return on Assets (ROA)	-37.31%	-37.42%	-18.72%	-7.06%	-4.13%	-7.05%
Return on Capital (ROIC)	-39.68%	-40.96%	-19.95%	-7.34%	-4.30%	-7.37%
Earnings Yield	-22.83%	-15.68%	-17.93%	-5.36%	-2.33%	-3.26%
FCF Yield	-15.20%	-15.90%	-13.20%	-4.54%	-2.81%	-2.61%
Buyback Yield / Dilution	-28.61%	-10.51%	-7.22%	-1.04%	-7.96%	-3.41%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.